- Home
- LKFN vs IMCR Comparison
LKFN vs IMCR Comparison
Compare LKFN & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LKFN
- IMCR
- Stock Information
- Founded
- LKFN 1872
- IMCR 2008
- Country
- LKFN United States
- IMCR United Kingdom
- Employees
- LKFN N/A
- IMCR N/A
- Industry
- LKFN Major Banks
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LKFN Finance
- IMCR Health Care
- Exchange
- LKFN Nasdaq
- IMCR Nasdaq
- Market Cap
- LKFN 1.7B
- IMCR 1.8B
- IPO Year
- LKFN 1997
- IMCR 2021
- Fundamental
- Price
- LKFN $65.02
- IMCR $35.24
- Analyst Decision
- LKFN Buy
- IMCR Buy
- Analyst Count
- LKFN 2
- IMCR 8
- Target Price
- LKFN $68.00
- IMCR $57.00
- AVG Volume (30 Days)
- LKFN 142.0K
- IMCR 290.9K
- Earning Date
- LKFN 10-24-2025
- IMCR 11-05-2025
- Dividend Yield
- LKFN 3.07%
- IMCR N/A
- EPS Growth
- LKFN N/A
- IMCR N/A
- EPS
- LKFN 3.67
- IMCR N/A
- Revenue
- LKFN $239,375,000.00
- IMCR $356,145,000.00
- Revenue This Year
- LKFN $16.89
- IMCR $31.83
- Revenue Next Year
- LKFN $4.98
- IMCR $8.50
- P/E Ratio
- LKFN $17.73
- IMCR N/A
- Revenue Growth
- LKFN N/A
- IMCR 26.78
- 52 Week Low
- LKFN $50.00
- IMCR $23.15
- 52 Week High
- LKFN $78.61
- IMCR $39.33
- Technical
- Relative Strength Index (RSI)
- LKFN 46.50
- IMCR 56.75
- Support Level
- LKFN $66.02
- IMCR $35.33
- Resistance Level
- LKFN $68.40
- IMCR $37.16
- Average True Range (ATR)
- LKFN 1.81
- IMCR 1.36
- MACD
- LKFN -0.32
- IMCR 0.32
- Stochastic Oscillator
- LKFN 24.87
- IMCR 53.39
About LKFN Lakeland Financial Corporation
Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.